Question

Remdesivir was originally created and developed in 2009 for hepatitis C infection by:

• A. \( \text{Gilead Sciences} \)
• B. \( \text{Takeda} \)
• C. \( \text{Toyama Chemical} \)
• D. \( \text{Novartis} \)

Hint:

Drug repurposing accelerates treatment discovery, allowing previously developed drugs to be used for new diseases.

Answer 1

The Correct Option is A

Remdesivir was originally developed by Gilead Sciences as an antiviral agent targeting hepatitis C. Later, it was repurposed for treating Ebola and gained prominence during the COVID-19 pandemic for its efficacy against SARS-CoV-2. It functions as a nucleotide analog inhibitor of RNA-dependent RNA polymerase.